Blockade of annexin A2 function in vivo, by gene ablation or by a diet leading to hyper-homocysteinemia, leads to loss of endothelial cell surface plasmin generation, reducing endothelial cell migratory capacity that leads to angiogenic failure (Flood and Hajjar, 2011). The gene discussed is ANXA2; the disease is hyperhomocysteinemia.